Abstract
2014), as well as brown adipose tissue (BAT) glucose metabolism (Steculorum et al., 2016) . 5
Here, we investigate the role of Agrp neurons in the control of peripheral substrate utilization. 6
Our data demonstrate that Agrp neuron activation rapidly regulates peripheral metabolism 7 independently of food ingestion. Specifically, Agrp neuron activation promotes lipogenesis via 8 sympathetic nervous system (SNS). These results highlight the complex function of these key 9 hypothalamic neurons in normal physiology and in disordered metabolic states, such as obesity. 10
Results

1
Acute switch in nutrient utilization upon Agrp activation 2
Nutrient utilization can be measured by indirect calorimetry, where the measurements of 3 VCO 2 production and VO 2 consumption are used to calculate the respiratory exchange ratio 4 (RER) ( Figure 1A ) (Frayn, 1983) . Under normal conditions, a RER approaching 0.7 indicates 5 predominant fat oxidation, while a RER approaching 1.0 indicates predominant carbohydrate 6 oxidation ( Figure 1A ) (Frayn, 1983 us to rapidly activate Agrp neurons without the necessity of tethers (as for example, using 17 optogenetics), facilitating the study of animals in indirect calorimetry chambers to measure gas 18 (O 2 and CO 2 ) exchange. Importantly, Trpv1-mediated activation of Agrp neurons is both rapid 19 (latency to start is ~2 min) and short lived (lasts ~1h), unlike the effects of activating Agrp 20 neurons via the designer receptor hM3Dq (Krashes et al., 2011) . 21
We injected mice with capsaicin during the light cycle and recorded concomitant changes 22 in locomotor activity and gas exchange for the ensuing 24 hours. Capsaicin injections produced 23 calories ingested from fat sources (0.4 kcal from fat, 'Fat Clamp'); (ii) limiting the amount of 1 calories ingested from carbohydrate sources (0.7 kcal from sugars, 'Sugar Clamp'), or (iii) 2 feeding animals isocaloric quantities of food (1.5 kcal from all sources, 'Cal Clamp'). 3
Before activation of Agrp neurons, baseline RER was 0.79 ± 0.003 (mean ± s.e.m.; n = 4 90 measurements), fat utilization was 0.51 ± 0.01 mg • min -1 (mean ± s.e.m.; n = 90 5 measurements) and carbohydrate utilization was 0.61 ± 0.02 mg • min -1 (mean ± s.e.m.; n = 90 6 measurements), indicating that in the conditions tested animals were using substrates from mixed carbohydrate utilization were strongly correlated to carbohydrate ingestion (r 2 = 0.90, P < 17 0.0001; Figure 2G ). Protein ingestion also correlated with carbohydrate utilization, but linear 18 regression analysis did not reach statistical significance (r 2 = 0.39, P = 0.07; Figure 2G ). Fat 19 intake did not correlate with carbohydrate utilization (r 2 = 0.07, P = 0.46; Figure 2G ). As 20 expected, these results demonstrated that carbohydrate levels in the diet are main players in the 21 metabolic shift that occurs upon food ingestion, suggesting that macronutrient quality rather than 22 caloric content account for these effects. 23
Agrp neurons control substrate utilization in the absence of ingestion 1
The effect of Agrp neuron activation on carbohydrate metabolism led us to further 2 explore the extent to which activation of Agrp neurons and sugar ingestion interact to rapidly 3 shift metabolism. We provided different concentrations of glucose to mice via gavage delivery, 4 thereby ruling out potential cephalic phase effects ( Figure 3A) . Gavage infusion of glucose led 5 to dose-dependent increases in RER ( Figure 3B ; r 2 = 0.99, P = 0.003), decreases in fat utilization 6 ( Figure 3C ; r 2 = 0.99, P = 0.004), and increases in carbohydrate utilization ( Figure 3D ; r 2 = 7 0.99, P = 0.003). These metabolic shifts were mainly due to increases in VCO 2 ( Figure 3F ; r 2 = 8 0.98, P = 0.006) and not VO 2 ( Figure 3E ; r 2 = 0.84, P = 0.07). Glucose intake also positively 9 correlated with energy expenditure ( Figure 3G ; r 2 = 0.92, P = 0.03), likely due to the thermic 10 effects of carbohydrate digestion. Activity levels were unchanged ( Figure 3D ; r 2 = 0.58, P = 11 0.23). These experiments demonstrate that small amounts of carbohydrate ingestion alone are 12 sufficient to shift metabolism even in the absence of carbohydrate sensing at the level of the 13 mouth. Thus, our previous results on substrate metabolism upon activation of Agrp neurons 14 could be simply explained by ingestion of carbohydrates. We designed the next experiments to 15 test this consideration. 16 We infused both control and Agrp Trpv1 mice with glucose (2 g/kg body weight, via 17 gavage) and activated Agrp neurons by injecting capsaicin (Figure 4A) . Strikingly, activation of 18
Agrp neurons led to an increased peak and a more sustained elevation of RER (Figure 4B ), an 19 effect that was present even in mice infused with saline ( Figure 4B) . Accordingly, activation of 20
Agrp neurons led to a sustained decrease in fat utilization ( Figure 4C ) and increase in 21 carbohydrate utilization (Figure 4D) , regardless of glucose infusion. These results strongly 22
suggest that activation of Agrp neurons alone is sufficient to promote shifts in substrate 23 utilization, independently of food consumption. However, even in animals infused with saline, 1 small amounts of liquid were delivered via gavage, raising the possibility that gastric distension 2 acts together with Agrp neuron activation to promote changes in substrate utilization. To exclude 3 this possibility, we repeated our experiments in a new cohort of mice in which Agrp neurons 4 were activated in the absence of food (Figure 4 supplement 1A) . In line with our previous 5 findings, activation of Agrp neurons alone was sufficient to increase RER (Figure 4 supplement 6 1B), while decreasing fat utilization (Figure 4 supplement 1G) and increasing carbohydrate 7 utilization (Figure 4 supplement 1H) . The above experiments demonstrate that Agrp neurons 8 rapidly control whole body substrate utilization by shifting metabolism towards carbohydrate 9 relative to fat utilization independently of ingestive behaviors. 10
Participation of lipogenesis in Agrp neuron-mediated shifts in metabolism 11
A physiological scenario in which the metabolic shift promoted by Agrp neuron 12 activation is expected to be important is during positive energy balance (i.e., a metabolic state 13 coupled to weight gain), as favoring carbohydrate utilization would allow storage of lipids and 14 re-route of energy substrates to undergo de novo lipogenesis, further increasing fat deposition. In 15 line with this, we found that, in absence of food ingestion, Agrp neuron activation decreased 16 circulating levels of non-esterified fatty acids (NEFAs, Figure 5B ) with no changes in blood 17 glucose levels ( Figure 5C ) in well-fed mice ( Figure 5A ). Because circulating NEFAs decrease 18 upon Agrp neuron activation, these results suggest a decrease in release, and possibly an increase 19 in deposition. To test this hypothesis, we measured expression levels of genes involved in lipid 20 metabolism in the white adipose tissue (WAT) from Agrp Trpv1 and control mice 60 minutes after 21 capsaicin injection. We found a decrease in the expression level of Ppara (Figure 5D ), a gene 22 involved in the promotion of fat catabolism. We also found a significant increase in expression 23 levels of hexokinase2 (hk2; Figure 5D ), a rate-limiting enzyme involved in glycolysis, a critical 1 metabolic step to provide carbons for de novo lipogenesis. Hormone-sensitive lipase (HSL) is an 2 essential step in the breakdown of triglycerides to release fatty acids in circulation. Activation of 3 HSP occurs by phosphorylation of this enzyme in several serine residues. Upon activation of 4
Agrp neurons, we found decreased levels of phosphorylated HSL (pHSL) in WAT compartments 5 ( Figure 5E ). Together, these experiments indicate activation of Agrp neurons leads to increased 6 lipogenesis and decreased lipolysis in the WAT. 7
De novo lipogenesis can drive RER above 1.0 (Frayn, 1983) , and could be a potential 8 factor involved in Agrp neuron mediated acute shifts in RER. Additionally, in our dietary clamp 9 experiments (Figure 2 ), we found negative results for fat utilization in mice that ate large 10 amounts of sugars (Figure 2 supplement 1F) . Because calculated fat utilization is the sum of 11 true rates of fat oxidation minus the rate of synthesis of fat from carbohydrates (de novo 12 lipogenesis) (Frayn, 1983) , an increase in synthesis leads to a net decrease in calculated fat 13 utilization. Thus, negative values for calculated fat utilization only occur when the rate of 14 synthesis is higher than the rate of oxidation (Frayn, 1983) , and are pathognomonic of ongoing 15 breaking down triglycerides to release free fatty acids in the circulation (Zeng et al., 2015) . 6
Lipolysis is critical for survival during periods of food scarcity, with fatty acids becoming the 7 predominant energy substrate. Conversely, inhibition of lipolysis favors lipogenesis, leading to 8 fat deposition (Rutkowski et al., 2015) . This is an important adaptive response to allow storage 9 of the excess of energy for later mobilization during food deprivation. However, when this 10 anabolic state (lipogenesis > lipolysis) is sustained it can become maladaptive and trigger 11 obesity. Here, we provided evidence that elevated activity of Agrp neurons is sufficient to 12 promote this shift in metabolism towards storage of nutrients (largely carbohydrates) as fat. and GABA, it is also possible that this multifaceted function of Agrp neurons arises from the 10 combination of released molecules. These findings have strong implications for our 11 understanding of how neuronal circuits involved in metabolism regulation function and, 12 consequently, to our understanding of severe disordered conditions such as obesity. 13 experiments. We did not observe any differences between the two control groups and, therefore, 7 throughout the manuscript we referred to them as "controls". We have carefully i.p.; experiments not reported). We also found that 10 mg/kg was the optimal dose to promote 13 changes in RER. Thus, we selected this dose of capsaicin for our studies. 14 The following mouse lines were used in this study: Agrptm1(cre)Lowl/J, 15
Experimental Procedures
Gt(ROSA)26Sortm1(Trpv1,ECFP)Mde/J, Trpv1tm1Jul/J. These lines are available from The 16 Jackson laboratories. All animals were kept in temperature and humidity controlled rooms, in a 17 12/12h light/dark cycle, with lights on from 7:00AM-7:00PM. Food and water were provided ad 18 libitum, unless otherwise stated. All procedures were approved by IACUC (Yale University). 19
Drugs 20
The following compounds were used in the reported studies: C75 (RPMI medium 1640; 21 from Tocris); capsaicin (3.3% Tween-80 in saline; from Sigma), and CL-316, 245 (in PBS; from 22 Tocris). All drugs were injected in a volume of 10 ml/kg of body weight intraperitoneally (i.p.). 1
When multiple injections were performed in the same experiment, the volume of each injection 2 was adjusted to a total volume of 10 ml/kg per animal. 3
Metabolic Assays and Biochemical Analysis 4
For all experiments animals were housed in individual cages at least three days prior to 5 the experiment. Blood samples were collected from the tail in order to measure glucose and free 6 fatty acids (NEFA) levels. Glucose was measured using a One Touch Ultra 2 glucometer. After 7 blood centrifugation, serum was collected and used to measure NEFA as indicated by 8 manufacturer (WAKO, Japan). 9
10
Gene Expression and Western blotting 11
Animals were deeply anesthetized with ketamine and xylazine and euthanized by 12 decapitation. Tissues were collected and frozen in liquid nitrogen. Tissues were lysed in buffer 13 containing 1% Nonidet P-40, 50 mM Tris 3 HCl, 0.1 mM EDTA, 150 mM NaCl, proteinase 14 inhibitors and protein phosphatase inhibitors. Equal amounts of protein lysate were 15 electrophoresed on SDS-PAGE gels and transferred to PVDF membranes. Primary antibodies 16 (Lipolysis Activation Antibody Sampler Kit #8334, Cell Signaling) were incubated at 4°C 17 overnight. Membranes were washed and incubated with secondary antibodies conjugated to 18 horseradish peroxidase. Protein levels were visualized using ECL chemiluminescent substrate 19 and quantified using ImageJ. 20
Total RNA was extracted from mouse tissues using RNeasy® lipid mini kit (Qiagen). 21 cDNA was reverse transcribed (Bio-Rad) and amplified with SYBR Green Supermix (Bio-Rad) 22 using a Light Cycler 480 real-time PCR system (Roche). Data were normalized to the expression 1 of Actin, Gusb and Arbp. Primer sequences are available on request. 2
Indirect calorimetry 3
Oxygen consumption (VO 2 ) and CO 2 production (VCO 2 ) were measured in four to eight 4 mice simultaneously in indirect calorimetry chambers (TSE Systems, Germany). Measurements 5 were recorded every 8-12 minutes over the entire course of the experiment (except for the 6 experiment in which ad libitum food intake was measured during one entire day). Respiratory 7 exchange ratio (RER) was calculated as the ratio between VCO 2 and VO 2 . Whole body fat 8 utilization was calculated using the follow equation: 1.67 * (VO 2 -VCO 2 ). Whole body 9 carbohydrate utilization was calculate using the follow equation: 4.55 * VCO 2 -3.21 * VO 2 10 (Frayn, 1983). All animals were single housed during the experiments in calorimetry chambers. 11
For the experiments in which different diets were fed to the animals, the following diets were 12 used: low-fat high-sugar diet (LFHS; D12450B, Open Source Diets, USA); high-fat diet 45% 13 calories from fat (HF45; D12451, Open Source Diets, USA); and high-fat diet 60% calories from 14 fat (HF60; D12492, Open Source Diets, USA). For the glucose response study, mice were 15 provided with glucose (D-Glucose, G8270, Sigma, USA) via gavage. We used saline as vehicle 16 and three doses of glucose (1, 2 and 3 g/kg body weight, via gavage feeding). Food was removed 17 2 hours before the experiment during the light cycle of the animals. Calorimetry was recorded 18 during 60 minutes prior injection of capsaicin and diet switch. For the experiments that no food 19 was provided, food was removed from the cages 2 hours before injecting mice with 20 capsaicin/vehicle. Baseline calorimetry was recorded for 60 minutes, and then the effects of 21
Agrp neuron activation were recorded for 60-120 minutes. Similar procedures were used in the 22 experiments in which compounds were given to mice prior the experiment. Glucose (2 g/kg, via 23 gavage), C75 (10 mg/kg, i.p.) or CL-316,243 (0.01-1.00 mg/kg, i.p) were given together with 1 capsaicin. In all cases, the drugs were injected immediately before capsaicin using two different 2 syringes. Total injected volume was adjusted for the maximal dose of 10 ml/kg mouse body 3 weight. 4 ANOVA was used to test for statistical differences within each experimental condition ('Clamp') 12 followed by Holm-Sidak's multiple comparisons test (MCT). MCTs are indicated as * P < 0.05, 13 ** P < 0.01, *** P < 0.001, and **** P < 0.0001. Large symbols indicate mean ± SEM. Small performed using two-way ANOVA on the mean response after gavage and capsaicin injection; 10 genotype (control vs. Agrp Trpv1 ) and gavage infusion (saline vs. glucose) were used as factors for 11 the ANOVA. Holm-Sidak's multiple comparisons test (MCT) was used to find post-hoc 12 differences among groups. MCTs are indicated as * P < 0.05, ** P < 0.01, *** P < 0.001, and 13 **** P < 0.0001 in figure panels. Control mice + saline gavage (n = 11); control mice + glucose 14 gavage (n = 12); Agrp Trpv1 mice+ saline gavage (n = 10); Agrp Trpv1 mice + glucose gavage (n = 15 
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Agrp
Trpv1 ) and drug (vehicle vs. C75) were used as factors for the ANOVA. Holm-Sidak's 20 multiple comparisons test (MCT) was used to find post-hoc differences among groups. MCTs are 21 indicated as * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 in figure panels. was performed using two-way ANOVA on the mean response after drug and capsaicin injection; 1 genotype (control vs. Agrp Trpv1 ) and drug (vehicle vs. CL316,243) were used as factors for the 2 ANOVA. Holm-Sidak's multiple comparisons test (MCT) was used to find post-hoc differences 3 among groups. MCTs are indicated as * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 4 0.0001 in figure panels. Control mice + vehicle (n = 9); control mice + CL316,243 (n = 9); 5 
